Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: Frequency distribution in a healthy German population

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH06-06-0312
Issue:2006: 96/4 (Oct) pp. 391-543
Pages:465-470

Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: Frequency distribution in a healthy German population

Berthold Hoppe, Farzaneh Tolou, Thomas Dörner, Holger Kiesewetter, Abdulgabar Salama
Institute of Transfusion Medicine, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, Germany

Summary

Evolvement and progression of cardiovascular diseases affecting the venous and arterial system are influenced by a multitude of environmental and hereditary factors. Many of these hereditary factors consist of defined gene polymorphisms, such as single nucleotide polymorphisms (SNPs) or insertion-deletion polymorphisms, which directly or indirectly affect the hemostatic system.The frequencies of individual hemostatic gene polymorphisms in different normal populations are well defined. However, descriptions of patterns of genetic variability of a larger extent of different factors of hereditary hypercoagulability in single populations are scarce.The aim of this study was i) to give a detailed description of the frequencies of factors of hereditary thrombophilia and their combinations in a German population (n = 282) and ii) to compare their distributions with those reported for other regions.Variants of coagulation factors [factor V 1691G>A (factor V Leiden), factor V 4070A>G (factor V HR2 haplotype), factor VII Arg353Gln, factor XIII Val34Leu, β-fibrinogen –455G>A, prothrombin 20210G>A], coagulation inhibitors [tissue factor pathway inhibitor 536C>T, thrombomodulin 127G>A], fibrinolytic factors [angiotensin converting enzyme intron 16 insertion/deletion, factor VII-activating protease 1601G>A (FSAP Marburg I), plasminogen activator inhibitor 1 –675 insertion/deletion (5G/4G), tissue plasminogen activator intron h deletion/insertion], and other factors implicated in influencing susceptibility to thromboembolic diseases [apolipoprotein E2/E3/E4, glycoprotein Ia 807C>T, methylenetetrahydrofolate reductase 677C>T] were included.The distribution of glycoprotein Ia 807C>T deviated significantly from the Hardy- Weinberg equilibrium, and a comparison with previously published data indicates marked region and ethnicity dependent differences in the genotype distributions of some other factors.

Keywords

thrombophilia, venous thromboembolism, atherothrombosis, SNP

DOI

http://dx.doi.org/10.1160/TH06-06-0312

You may also be interested in...

1.

Francis Couturaud1, Jérôme Duchemin2, Christophe Leroyer1, Bénédicte Delahousse3, Jean François Abgrall2, Dominique Mottier1, for the Groupe d’Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O)

Thrombosis and Haemostasis 2008 99 1: 223-228

http://dx.doi.org/10.1160/TH07-08-0515

2.

B. Cosmi (1), C. Legnani (1), M. Cini (1), G. Guazzaloca (1), G. Palareti (1)

Thrombosis and Haemostasis 2011 105 5: 837-845

http://dx.doi.org/10.1160/TH10-08-0559

3.

R. B. Zotz1, C. Sucker2, A. Gerhardt3

Hämostaseologie 2008 28 5: 455-464



Articles

You've 483 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...